We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Events

19 May 2026 - 22 May 2026
17 Jun 2026 - 19 Jun 2026

New Treatment for Allergies Shows Promise

By HospiMedica staff writers
Posted on 10 Dec 2002
Precinical studies have shown promising results for a new allergy therapy based on Notch, a cell surface protein able to switch off an immune response to a specific allergen.

By inducing antigen-specific regulatory T cells to re-direct the immune response, an antigen is presented to the immune system in the presence of a Notch stimulator. More...
In addition to switching off the allergic response, the body learns to tolerate the antigen so that future contact does not result in the mounting of an allergic response. In the preclinical studies, treatment with a Notch stimulator/dust mite antigen combination delivered by needle-free, particle-mediated delivery resulted in a significant modification of the immune response.

The new approach was developed by Lorantis Ltd. (Cambridge, UK). The delivery system was supplied by PowderJect Pharmaceuticals Plc (Oxford), which is developing a broad range of vaccines based on its delivery technology.




Related Links:
Lorantis
PowderJect

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Gold Member
12-Channel ECG
CM1200B
New
Blood Gas Analyzer
i-Check200
New
Glucose Meter
StatStrip®
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Copyright © 2000-2026 Globetech Media. All rights reserved.